Roivant Sciences Ltd. (ROIV)
NASDAQ · Manufacturing · Pharmaceutical preparations
ROIV price, last 12 months
Key stats
- Previous close
- $38.73
- Open
- $39.08
- Day range
- $38.75 – $39.79
- 52-week range
- $19.96 – $42.50
- Volume
- 4.9M
- Avg volume (20 days)
- 7.9M
- Market cap
- $28.6B
Performance
Technicals and fundamentals
About Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $28.6B